10TH ANNUAL CLINICAL CONTROVERSIES: AN INTERACTIVE EVENING FOR ENDOCRINOLOGY & CARDIOLOGY SPECIALISTS (AS-113)

Thursday, October 26, 2023

18:30 – 20:30 EST

Location: Hotel William Gray

Target Audience: MDs, Cardiologists

Chair(s)

Alexander Abitbol, MDCM, FRCPC

Endocrinologist & Assistant Medical Director
LMC Healthcare

Presenter(s)

Harpreet S. Bajaj, MD, MPH, ECNU, FACE (he/him/his)

Endocrinologist & Medical Director, Endocrine and Metabolic Research
LMC Healthcare
Diabetes Canada
Jeremy Gilbert, MD,FRCPC

MD, FRCPC
Sunnybrook Health Sciences Centre, University of Toronto
University of Toronto
Shelley Zieroth, MD

Heart Failure Cardiologist, Past President CHFS
St. Boniface Hospital
University of Manitoba
JG

Jean Grégoire, MD, FRCP(c), FCCS, FACC

Interventional Cardiologist
Institut de cardiologie de Montréal and Université de Montréal

Planning Committee Member(s)

Ronald M. Goldenberg, MD, FRCPC, FACE (he/him/his)

Consultant Endocrinologist
LMC Diabetes & Endocrinology

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

discuss cardiovascular considerations when selecting between dual incretin agonists (GIP/GLP-1) and high dose GLP-1 receptor agonists;
review the sequence of emerging medications aimed at reducing the risk of hospitalization for heart failure;
consider the use of continuous glucose monitors in a hospital setting; and
individualize lipid management tackling residual cardiovascular risk.

By invitation only; space is limited: RSVP@lmc.ca

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Society of Endocrinology and Metabolism. You may claim a maximum of 1.5 hours (credits are automatically calculated). This program was codeveloped and planned with CSEM and LMC Healthcare to achieve scientific integrity, objectivity, and balance.